… rapidly despite the financial pressure on farmers, a clear indication that our products are delivering on their value proposition. We expect to launch eight to 10 new products in 2026, including two new products that were launched during the first quarter. We expect Mosaic Biosciences revenues to double again in 2026. I also want to touch on our work on rare earth elements. which represents a long-term growth opportunity for Mosaic. In March, we announced a project development agreement with Rainbow Rare Earths following a positive economic assessment of the Ubaraba gypstack in Brazil. The project would recover rare earth elements from phosphogypsum rather than through traditional hard rock mining, leveraging existing byproducts from our operations. We are evaluating similar opportunities for rare earth extraction in the U.S., and early findings are encouraging. This is a long-term opportunity, and we are advancing it in a disciplined, phased manner consistent with our investment criteria. To conclude, clearly, we and the rest of the industry are operating in a challenging climate. Overall, we are managing with speed and agility, taking actions that are required by our current …